Bicocca Open Archive

Logo unimib boa

Montillo, M., Tedeschi, A., Rossi, V., Cafro, A., Cairoli, R., Veronese, S., et al. (2004). Alemtuzumab as consolidation after a response to fludarabine is effective to purge residual disease in patients with chronic lymphocytic leukemia. In 46th Annual Meeting of the American-Society-of-Hematology (pp.140-140). American Society of Hematology [10.1182/blood.V104.11.479.479].

Alemtuzumab as consolidation after a response to fludarabine is effective to purge residual disease in patients with chronic lymphocytic leukemia

Cairoli, R;
2004
paper
Hematology
English
46th Annual Meeting of the American-Society-of-Hematology - DEC 04-07, 2004
2004
46th Annual Meeting of the American-Society-of-Hematology
BLOOD
2004
104
11 Part1
140
140
479
none
Montillo, M., Tedeschi, A., Rossi, V., Cafro, A., Cairoli, R., Veronese, S., et al. (2004). Alemtuzumab as consolidation after a response to fludarabine is effective to purge residual disease in patients with chronic lymphocytic leukemia. In 46th Annual Meeting of the American-Society-of-Hematology (pp.140-140). American Society of Hematology [10.1182/blood.V104.11.479.479].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/411475
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
Social impact